H.R. 2021, Investing for the People Act of 2019, budget legislation, potential provisions relating to prescription drug pricing, reporting and oversight.
H.R. 2113, the Prescription Drug Sunshine, Transparency, Accountability and Reporting Act or Prescription Drug STAR Act, provisions relating to prescription drug pricing, reporting and oversight requirements. H.R. 965, the Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act of 2019, provisions that would establish a process by which generic manufacturers could obtain sufficient quantities of brand drug samples for testing
H.R. 1046, Medicare Negotiation and Competitive Licensing Act of 2019, provisions relating to prescription drug pricing and intellectual property rights.
HCR - Health Issues MMM - Medicare/Medicaid
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
CAPITOL HILL STRATEGIES,  LLC
660 Pennsylvania Avenue, SE Suite 202, Washington, DC, 20003, US
CHARLES M BRAIN (Asst. to the President, Dp. Chief of Staff W&M Cmte.) A. J. WOJCIAK (Senior Legislative Asst., Cong. Earl Pomeroy) CHARLES M BRAIN (Asst. to the President, Dp.Chief Staff W&M Cmte) A. J. WOJCIAK (Senior Legislative Asst., Cong. Earl Pomeroy)
Asst. to the President, Dp. Chief of Staff W&M Cmte. Senior Legislative Asst., Cong. Earl Pomeroy Asst. to the President, Dp.Chief Staff W&M Cmte Senior Legislative Asst., Cong. Earl Pomeroy